Alucent Biomedical Announces First Patient Enrolled in Phase 1 Natural Vascular Scaffolding Clinical Trial
Multicenter ACTIVATE I Study to Enroll up to 15 Patients in the U.S. SALT LAKE CITY–(BUSINESS WIRE)–#AlucentNVS—Alucent Biomedical Inc. announced…